ascorbic acid, cholecalciferol, .alpha.-tocopherol, dl-, folic acid, levomefolate calcium, pyridoxine hydrochloride, cyanocobalamin, calcium formate, ferrous asparto glycinate, magnesium oxide and doconexent · LEVOMEFOLATE CALCIUM 600 ug/1; ASCORBIC ACID 90 mg/1; CHOLECALCIFEROL 10 ug/1; .ALPHA.-TOCOPHEROL, DL- 18 mg/1; FOLIC ACID 400 ug/1; PYRIDOXINE HYDROCHLORIDE 26 mg/1; CYANOCOBALAMIN 25 ug/1; CALCIUM FORMATE 160 mg/1; FERROUS ASPARTO GLYCINATE 18 mg/1; MAGNESIUM OXIDE 50 mg/1; DOCONEXENT 300 mg/1 · Capsule, Gelatin Coated · Oral · Avion Pharmaceuticals, LLC
NDC 75854-0312-30 · 30 CAPSULE, GELATIN COATED in 1 BOTTLE · UNAPPROVED DRUG OTHER · View full market →
Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $12.82 per unit over the past year. Put together: worth watching — several of the pressures that precede supply trouble are present at once.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.
The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Avion Pharmaceuticals, LLC | LEVOMEFOLATE CALCIUM 600 ug/1; ASCORBIC ACID 90 mg/1; CHOLECALCIFEROL 10 ug/1; .ALPHA.-TOCOPHEROL, DL- 18 mg/1; FOLIC ACID 400 ug/1; PYRIDOXINE HYDROCHLORIDE 26 mg/1; CYANOCOBALAMIN 25 ug/1; CALCIUM FORMATE 160 mg/1; FERROUS ASPARTO GLYCINATE 18 mg/1; MAGNESIUM OXIDE 50 mg/1; DOCONEXENT 300 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Avion Pharmaceuticals, LLC | LEVOMEFOLATE CALCIUM 18 mg/1; ASCORBIC ACID 90 mg/1; CHOLECALCIFEROL 160 mg/1; .ALPHA.-TOCOPHEROL, DL- 10 ug/1; FOLIC ACID 25 ug/1; PYRIDOXINE HYDROCHLORIDE 300 mg/1; CYANOCOBALAMIN 18 mg/1; CALCIUM FORMATE 400 ug/1; FERROUS ASPARTO GLYCINATE 600 ug/1; MAGNESIUM OXIDE 50 mg/1; DOCONEXENT 26 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Avion Pharmaceuticals, LLC | .ALPHA.-TOCOPHEROL, DL- 18 mg/1; ASCORBIC ACID 90 mg/1; CALCIUM FORMATE 160 mg/1; CHOLECALCIFEROL 10 ug/1; CYANOCOBALAMIN 25 ug/1; DOCONEXENT 300 mg/1; FERROUS ASPARTO GLYCINATE 18 mg/1; FOLIC ACID 400 ug/1; LEVOMEFOLATE CALCIUM 600 ug/1; MAGNESIUM OXIDE 50 mg/1; PYRIDOXINE HYDROCHLORIDE 26 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Prenate Dha — NDC 75854-0312-30," retrieved September 3, 2026, https://drugdashboards.com/drug/75854031230.
Free to cite with attribution — see how the data is put together.